Larimar Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €298.32M +110.3% €41.85M -181.4% 14.0% +0.50 pp N/A N/A
    (estimated) €141.87M +263.9% -€51.41M -57.5% -36.2% +2.7 pp N/A N/A
    (estimated) €38.99M +1,850.4% -€120.82M -8.5% -309.9% +63 pp N/A N/A
    (estimated) €2.00M +∞% -€132.07M +25.4% -6,607.3% -66 pp -€104.86M +11.8% -5,246.1% -52 pp
    (estimated) €0.00 +NaN% -€105.31M +51.6% N/A -€93.81M +55.0% N/A
    €0.00 +NaN% -€69.44M +118.1% N/A -€60.52M +111.0% N/A
    €0.00 +NaN% -€31.83M +8.1% N/A -€28.69M +21.2% N/A
    €0.00 +NaN% -€29.45M -32.1% N/A -€23.67M -34.2% N/A
    €0.00 +NaN% -€43.34M +18.9% N/A -€35.99M -0.9% N/A
    €0.00 +NaN% -€36.47M +83.0% N/A -€36.30M +86.3% N/A
    €0.00 +NaN% -€19.93M -62.3% N/A -€19.48M -56.0% N/A
    €0.00 +NaN% -€52.87M +18.0% N/A -€44.27M +17.5% N/A
    €0.00 +NaN% -€44.82M -10.1% N/A -€37.67M -14.8% N/A
    €0.00 +NaN% -€49.86M -22.1% N/A -€44.21M -13.0% N/A
    €0.00 +NaN% -€64.00M +103.1% N/A -€50.80M +109.2% N/A
    €0.00 +NaN% -€31.51M +160.7% N/A -€24.28M +88.0% N/A
    €0.00 +NaN% -€12.08M +1.1% N/A -€12.91M +10.3% N/A
    €0.00 -€11.96M N/A -€11.71M N/A

    Notifications